RSS Feed
YouTube
SoundCloud
Instagram
Twitter
Facebook
Search
Submit Search
Close Menu
Search
Home
Latest Stories
Top Stories
Campus
City
Sports
Arts and Entertainment
Opinion
Multimedia
In Focus
Wildcat GeoGame
The Daily Northwestern
Menu
The Daily Northwestern
Campus
Academic
Administration
Alumni
Campus Safety
Events
Faculty
Student Government
ASG Elections
Student Groups
All Stories
City
Arts and Technology
Business
Crime
Education
Politics
Features
Evanston Organizes
Portrait of a Ward
All Stories
Sports
Football
Men’s Basketball
Women’s Basketball
Lacrosse
Softball
Baseball
Opinion
Columns
Editorials
The Spectrum
Letters to the Editor
FAQ
Multimedia
Podcasts
The Weekly
The Daily Bounce
Behind the Byline
Uncommon Conversations
Cats Chat
Office Hours
The Spectrum
The Football Podcast
Video
Group Spotlight
Coming to Cook County
Digital Projects
Captured: Photo Blog
Data Visualization
A&E
The Monthly
Theater
Music
Television and Film
Dance
Visual Arts
Literature
In Focus
Donate
About
Advertise
Classifieds
Comment Policy
Editorial Board
Former Daily Editors
Join Us
Awards
Pulitzer-Winning Alumni
Geogame
Print Archives
Social Media
Contact
Terms of Use
More
»
In Focus: As Lyrica profits dry up, Northwestern seeks another ‘blockbuster’ drug
April 10, 2016
